PIEZO1 and Hepatic fibrosis: In liver fibrosis and HCC, Piezo1 activation mediates Ca2+ influx, leading to activation of pro-fibrotic and pro-tumorigenic pathways, such as TGF-β and Hippo/YAP signaling, thus promoting disease progression.